Asthma and obesity: endotoxin another insult to add to injury? N Lad, AM Murphy, C Parenti, CP Nelson, NC Williams, GR Sharpe, ... Clinical Science 135 (24), 2729-2748, 2021 | 16 | 2021 |
Identification and validation of ERK5 as a DNA damage modulating drug target in glioblastoma N Carmell, O Rominiyi, KN Myers, C McGarrity-Cottrell, A Vanderlinden, ... Cancers 13 (5), 944, 2021 | 13 | 2021 |
RDNA-12. THE FANCONI ANAEMIA (FA) PATHWAY AND GLIOBLASTOMA: A NEW FOUNDATION FOR DNA DAMAGE RESPONSE TARGETED COMBINATIONS O Rominiyi, K Myers, N Gomez-Roman, N Lad, D Dar, D Jellinek, ... Neuro-Oncology 21 (Suppl 6), vi209, 2019 | 3 | 2019 |
P04. 74 Preclinical evaluation of combinations targeting the DNA damage response in 2D and 3D models of glioblastoma stem cells O Rominiyi, N Gomez-Roman, N Lad, Y Al-Tamimi, DA Jellinek, ... Neuro-oncology 20 (suppl_3), iii297-iii297, 2018 | 2 | 2018 |
Investigating the effect of obesity on gut damage, systemic inflammation, enhanced asthma severity due to gut derived bacteria, endotoxin C Parenti, AM Murphy, N Lad, PG McTernan, CP Nelson, GR Sharpe, ... Endocrine Abstracts 86, 2022 | 1 | 2022 |
The effect of novel adipokine asprosin on mitochondrial function in human airway epithelial cells N Lad, AM Murphy, C Parenti, NC Williams, CP Nelson, GR Sharpe, ... Endocrine Abstracts 86, 2022 | 1 | 2022 |
The role of SCFAs to reduce endotoxin and asprosin induced inflammation in human lung epithelial and adipocyte cells N Lad, AM Murphy, C Parenti, NC Williams, CP Nelson, GR Sharpe, ... Proceedings of the Nutrition Society 81 (OCE4), E116, 2022 | 1 | 2022 |
Overweight and obese poorly controlled severe asthma patients have increased levels of gut permeability biomarkers lipopolysaccharide-binding protein (LBP) and calprotectin C Parenti, AM Murphy, N Lad, PG McTernan, CP Nelson, GR Sharpe, ... Proceedings of the Nutrition Society 81 (OCE4), E117, 2022 | 1 | 2022 |
Asprosin impact on mitochondrial metabolism in obese adipose tissue, a tale of two depots? N Lad, AM Murphy, C Parenti, CP Nelson, NC Williams, GR Sharpe, ... Endocrine Abstracts 77, 2021 | 1 | 2021 |
Biomarkers of gut permeability are elevated in difficult to control asthma patients C Parenti, A Murphy, N Lad, P Mcternan, C Nelson, G Sharpe, C Barber, ... ERJ Open Research 10 (suppl 14), 2024 | | 2024 |
The gut microbiota as a novel nutritional target to influence systemic inflammation associated with prevalent health disorders N Lad PQDT-Global, 2023 | | 2023 |
Investigating levels of gut permeability markers in blood from patients with severe asthma across body mass index (BMI) C Parenti, AM Murphy, N Lad, PG McTernan, CP Nelson, GR Sharpe, ... ACTA PHYSIOLOGICA 236, 425-428, 2022 | | 2022 |
Short chain fatty acids as mediators of airway inflammation induced by endotoxin and asprosin N Lad, AM Murphy, C Parenti, NC Williams, CP Nelson, GR Sharpe, ... ACTA PHYSIOLOGICA 236, 443-445, 2022 | | 2022 |
Lipocalin 2, a mediator or marker of adipocyte dysfunction? C Parenti, N Lad, CN Williams, GR Sharpe, CP Nelson, AM Murphy, ... Endocrine Abstracts 77, 2021 | | 2021 |